TheProfitWatch

PYXS - Pyxis Oncology, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.24 0.47 (14.51%) --- -0.03 (-0.8%) -0.01 (-0.27%) 0.0 (0.0%) 0.42 (12.77%) 0.04 (1.09%) 0.04 (1.09%)

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.3
Diluted EPS:
-0.3
Basic P/E:
-12.3667
Diluted P/E:
-12.3667
RSI(14) 1m:
33.5
VWAP:
3.71
RVol:

Events

Period Kind Movement Occurred At

Related News